# Syed K. Lateef, M.D. – FDA Inspection, Jun 2, 2023

Source: https://www.keypedia.com/records/fda_inspections/syed-k-lateef-md/467198de-5b31-4df9-a9c1-82e04dec69be
Source feed: FDA_Inspections

> FDA inspection 1206825 of Syed K. Lateef, M.D., June 02, 2023. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 312. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1206825
- Company Name: Syed K. Lateef, M.D.
- Inspection Date: 2023-06-02
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Officers

- [Company Rep](https://www.keypedia.com/people/sheri-l-stephenson/dd4f3755-bb3b-4a14-a08f-8d59fbb0b6fa)

Company: https://www.keypedia.com/companies/syed-k-lateef-md/f4576215-3e8b-49b8-8c29-05dba41d1816

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c